Popular Stories
RADAR on Medicare Advantage
-
CMS on Oct. 10 revealed that 40% of Medicare Advantage Prescription Drug (MA-PD) plans — or 209 contracts — that will be offered in 2025 earned an overall Star Rating of 4 or higher, thus qualifying for quality...
-
In the weeks following the Sept. 27 release of the 2025 Medicare Advantage and Part D landscape files and other key information, experts taking a deeper look at next year’s plan offerings agree that there’s not...
HEALTH PLAN WEEKLY
-
The Cigna Group on Oct. 31 posted third-quarter results that exceeded most analysts’ projections, bucking the industry trends that other managed care organizations have revealed in recent weeks. Unlike those...
-
Humana’s third-quarter 2024 earnings results were better than many analysts feared, driven by higher-than-expected Medicare Advantage (MA) revenue and outperformance of the company’s CenterWell clinics...
Radar On Speciality Pharmacy
-
In the seven years since the approval of the first chimeric antigen receptor T-cell (CAR-T) therapy, the agents have proved to be effective in the treatment of non-Hodgkin lymphoma. But the one-time-use agents...
-
Recently publicized data from a late-stage clinical trial for an HIV pre-exposure prophylaxis (PrEP) therapy showed promise for twice-yearly treatments, potentially boosting compliance, according to industry...
RADAR ON DRUG BENEFITS
-
On the same day that the Biden administration proposed a rule that would require health insurers to cover over-the-counter birth control, it released a less-heralded guidance document that makes another...
-
Only 27% of stand-alone Medicare Part D Prescription Drug Plans (PDPs) — or 11 contracts — earned 4 stars or higher for the 2025 plan year, according to CMS’s 2025 Medicare Advantage and Part D Star Ratings...
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.